19.09 15:00 | dpa-AFX: GNW-Adhoc: PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics |
17.09 15:00 | dpa-AFX: GNW-Adhoc: Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection |
13.09 15:00 | dpa-AFX: GNW-Adhoc: RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress |
11.09 15:15 | dpa-AFX: GNW-Adhoc: RenovaroCube Announces Strategic Offering of Up to 20% Ownership |
14.06 15:06 | dpa-AFX: GNW-Adhoc: Renovaro, Inc. Announces $10 million in Equity Committed |
24.05 15:20 | dpa-AFX: GNW-Adhoc: Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy |
30.04 17:00 | dpa-AFX: GNW-Adhoc: Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics |
24.04 15:00 | dpa-AFX: GNW-Adhoc: RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership |
18.04 14:45 | dpa-AFX: GNW-Adhoc: Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diag |
15.02 15:25 | dpa-AFX: GNW-Adhoc: Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace |
14.02 16:01 | dpa-AFX: GNW-Adhoc: Statement of Renovaro Inc |
13.02 15:46 | dpa-AFX: GNW-Adhoc: Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace |
13.02 15:31 | dpa-AFX: GNW-Adhoc: AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine |
25.01 18:45 | dpa-AFX: GNW-Adhoc: Renovaro Biosciences Announces Results of Special Meeting of Shareholders |
16.01 14:00 | dpa-AFX: GNW-Adhoc: Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD |
11.10 15:25 | dpa-AFX: GNW-Adhoc: Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors |
10.10 14:00 | dpa-AFX: GNW-Adhoc: Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors |
02.10 18:05 | dpa-AFX: GNW-Adhoc: Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD |
02.10 15:25 | dpa-AFX: GNW-Adhoc: AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine |
|